BioTissue, Inc. - TissueTech, Inc.
Bio-Tissue® Inc was founded in 1997 due to an unmet need for a better surgical and therapeutic alternative for ocular surface conditions; one that would serve as a non-immunogenic tissue replacement and would facilitate tissue regeneration.
Initial research began in the 1980’s, led by Scheffer C.G. Tseng, MD, PhD, who believed the solution was to utilize the natural regenerative properties of human amniotic membrane tissue to promote wound healing.
In the late 1990’s, Dr. Tseng introduced the use of amniotic membrane for ocular surface reconstruction, by utilizing a novel method of processing and preservation – the CryoTek® Method.
Today, the company’s regenerative wound healing solutions are used by eye care professionals around the world.